Kellie M. Tainton

2.2k total citations
19 papers, 1.5k citations indexed

About

Kellie M. Tainton is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Kellie M. Tainton has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Immunology. Recurrent topics in Kellie M. Tainton's work include Drug Transport and Resistance Mechanisms (6 papers), Immune Cell Function and Interaction (5 papers) and Genomics and Chromatin Dynamics (3 papers). Kellie M. Tainton is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Immune Cell Function and Interaction (5 papers) and Genomics and Chromatin Dynamics (3 papers). Kellie M. Tainton collaborates with scholars based in Australia, United States and Austria. Kellie M. Tainton's co-authors include Ricky W. Johnstone, Mark J. Smyth, Astrid A. Ruefli, David Bernhard, Reinhard Kofler, Vivien R. Sutton, Michael J. Ausserlechner, Alyssa E. Barry, K. H. Andy Choo and Michael Cancilla and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Kellie M. Tainton

19 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kellie M. Tainton 1.2k 533 296 200 177 19 1.5k
Eric Julien 1.2k 1.0× 219 0.4× 119 0.4× 176 0.9× 155 0.9× 28 1.5k
Andreas Kloetgen 1.2k 1.0× 164 0.3× 278 0.9× 70 0.3× 207 1.2× 30 1.5k
Takehisa Matsumoto 1.4k 1.2× 288 0.5× 210 0.7× 162 0.8× 54 0.3× 44 1.8k
Annahita Sallmyr 957 0.8× 276 0.5× 94 0.3× 109 0.5× 143 0.8× 26 1.3k
Hai Dang Nguyen 1.6k 1.4× 571 1.1× 178 0.6× 167 0.8× 67 0.4× 38 1.8k
Arnaud Coquelle 1.2k 1.0× 406 0.8× 108 0.4× 370 1.9× 69 0.4× 16 1.5k
Hui Cao 1.4k 1.2× 66 0.1× 195 0.7× 158 0.8× 105 0.6× 44 1.7k
Qing Sang 475 0.4× 206 0.4× 319 1.1× 74 0.4× 99 0.6× 51 1.2k
Luigi Nezi 1.5k 1.3× 326 0.6× 254 0.9× 199 1.0× 107 0.6× 26 1.9k
J.J. Keusch 795 0.7× 171 0.3× 45 0.2× 123 0.6× 228 1.3× 22 1.1k

Countries citing papers authored by Kellie M. Tainton

Since Specialization
Citations

This map shows the geographic impact of Kellie M. Tainton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kellie M. Tainton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kellie M. Tainton more than expected).

Fields of papers citing papers by Kellie M. Tainton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kellie M. Tainton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kellie M. Tainton. The network helps show where Kellie M. Tainton may publish in the future.

Co-authorship network of co-authors of Kellie M. Tainton

This figure shows the co-authorship network connecting the top 25 collaborators of Kellie M. Tainton. A scholar is included among the top collaborators of Kellie M. Tainton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kellie M. Tainton. Kellie M. Tainton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Neeson, Paul J., Edwin Leeansyah, Kellie M. Tainton, et al.. (2013). Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy. Clinical & Experimental Immunology. 175(1). 49–58. 39 indexed citations
2.
Neeson, Paul J., Edwin Leeansyah, Kellie M. Tainton, et al.. (2010). Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients. Leukemia. 24(3). 592–600. 31 indexed citations
3.
Peinert, Stefan, H. Miles Prince, Michael H. Kershaw, et al.. (2010). Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen. Gene Therapy. 17(5). 678–686. 98 indexed citations
4.
Neeson, Paul J., Kellie M. Tainton, H. Miles Prince, et al.. (2010). Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype. Gene Therapy. 17(9). 1105–1116. 36 indexed citations
6.
Hasthorpe, Suzanne, Kellie M. Tainton, Melissa J. Peart, et al.. (2007). G2/M checkpoint gene expression in developing germ cells. Molecular Reproduction and Development. 74(5). 531–538. 6 indexed citations
7.
Ludlow, Louise, Linda Hii, Andrea Newbold, et al.. (2007). Cloning and characterisation of Ifi206: A new murine HIN‐200 family member. Journal of Cellular Biochemistry. 103(4). 1270–1282. 8 indexed citations
8.
Tainton, Kellie M., Mark J. Smyth, Jacob T. Jackson, et al.. (2004). Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux. Cell Death and Differentiation. 11(9). 1028–1037. 89 indexed citations
9.
Peart, Melissa J., Kellie M. Tainton, Astrid A. Ruefli, et al.. (2003). Novel mechanisms of apoptosis induced by histone deacetylase inhibitors.. PubMed. 63(15). 4460–71. 204 indexed citations
10.
Ruefli, Astrid A., Kellie M. Tainton, Phillip K. Darcy, Mark J. Smyth, & Ricky W. Johnstone. (2002). P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation. Cell Death and Differentiation. 9(11). 1266–1272. 64 indexed citations
11.
Ruefli, Astrid A., David Bernhard, Kellie M. Tainton, et al.. (2002). Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P‐glycoprotein‐expressing cells. International Journal of Cancer. 99(2). 292–298. 68 indexed citations
12.
Johnstone, Ricky W., Kellie M. Tainton, Astrid A. Ruefli, et al.. (2001). P-glycoprotein Does Not Protect Cells against Cytolysis Induced by Pore-forming Proteins. Journal of Biological Chemistry. 276(20). 16667–16673. 24 indexed citations
13.
Ruefli, Astrid A., Michael J. Ausserlechner, David Bernhard, et al.. (2001). The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. Proceedings of the National Academy of Sciences. 98(19). 10833–10838. 410 indexed citations
14.
Barry, Alyssa E., Emily V. Howman, Michael Cancilla, et al.. (2000). The 10q25 Neocentromere and its Inactive Progenitor Have Identical Primary Nucleotide Sequence: Further Evidence for Epigenetic Modification. Genome Research. 10(6). 832–838. 35 indexed citations
15.
Tainton, Kellie M., Astrid A. Ruefli, Mark J. Smyth, & Ricky W. Johnstone. (2000). Equivalent Death of P-Glycoprotein Expressing and Nonexpressing Cells Induced by the Protein Kinase C Inhibitor Staurosporine. Biochemical and Biophysical Research Communications. 276(1). 231–237. 13 indexed citations
16.
Johnstone, Ricky W., et al.. (2000). A Role for P-Glycoprotein in Regulating Cell Death. Leukemia & lymphoma. 38(1-2). 1–11. 96 indexed citations
17.
Cancilla, Michael, Kellie M. Tainton, Alyssa E. Barry, et al.. (1998). Direct Cloning of Human 10q25 Neocentromere DNA Using Transformation-Associated Recombination (TAR) in Yeast. Genomics. 47(3). 399–404. 32 indexed citations
18.
Graves, Joan P., Lydia E. Matesic, Roger H. Reeves, et al.. (1998). Rapid cloning of mouse DNA as yeast artificial chromosomes by transformation-associated recombination (TAR). Mammalian Genome. 9(2). 157–159. 11 indexed citations
19.
Sart, Desirée du, Michael Cancilla, Elizabeth D. Earle, et al.. (1997). A functional neo-centromere formed through activation of a latent human centromere and consisting of non-alpha-satellite DNA. Nature Genetics. 16(2). 144–153. 276 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026